^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

anitocabtagene autoleucel (CART-ddBCMA)

i
Other names: CART-ddBCMA, ddBCMA T Cell Therapy, KITE-772, anito-cel, KITE772, KITE 772
Associations
Trials
Company:
Arcellx, Gilead
Drug class:
BCMA-targeted CAR-T immunotherapy
Related drugs:
Associations
Trials